Kaken Pharmaceutical Co., Ltd. (4521.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 156.95B |
| Enterprise Value | 116.09B |
| P/E Ratio | 14.63 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 1.71 |
| Price/Book Ratio | 0.99 |
| Enterprise/Revenue | 1.1 |
| Enterprise/EBITDA | 5.87 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 76.87B |
| Revenue/Share | 2,328.02 |
| Gross Profit | 39.24B |
| EBITDA | 5.68B |
| Net Income | 2.14B |
| Diluted EPS | 56.55 |
Balance Sheet
| Total Cash | 58.14B |
| Total Cash/Share | 1,535.4 |
| Total Debt | 4.26B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.18 |
| Book Value Per Share | 4,037.29 |
Price History
| 52-Week Change | 2.65 |
| 52-Week High | 4,445 |
| 52-Week Low | 3,540 |
| Moving Average 50 Days | 3,870.7 |
| Moving Average 200 Days | 4,013.25 |
Statistics
| Average Volume | 124,211 |
| Shares Outstanding | 37.87M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 190 |
| Trailing Annual Dividend Yield | 4.77 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | September 28, 2015 |
AD
